“…While recent studies showed that treatment response might improve with diffusion magnetic resonance imaging (MRI) guided DBS targeting ( Baldermann et al, 2019 , Coenen et al, 2017 , Liebrand et al, 2019 ), it is unlikely that all patients will become responders in the future. Since OCD has been associated with various structural brain abnormalities ( Boedhoe et al, 2017 , Gan et al, 2017 , Hashimoto et al, 2014 ), differences in (individual) brain structure might be used to predict treatment response. Multiple studies used structural MRI data to predict treatment outcome in OCD (e.g., ( Hashimoto et al, 2014 , Yun et al, 2015 )), but few studies examined neural biomarkers for treatment-resistant OCD ( Dunlop et al, 2016 , Van Laere et al, 2006 ).…”